Eovist Injection, Solution
Product Images NDC 50419-320

2 FDA label images from Bayer Healthcare Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Eovist (NDC 50419-320). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

Structure (Image 01)
Chemical structure of Gadoxetate Disodium, the active ingredient in EOVIST injection solution. The diagram shows the molecular arrangement including the gadolinium (Gd) ion complexed with organic ligands and sodium ions.*
FDA Label Image

Carton 10 mL (Image 02)

Carton 10 mL (Image 02)
Eovist 181.43 mg/mL (gadoxetate disodium) injection solution for intravenous use, provided in a 5 vial pack with each vial containing 10 mL. The label shows the Bayer logo and specifies single-dose vials with storage instructions and a note on recommended dose from prescribing information. Labeler is Bayer HealthCare Pharmaceuticals Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.